Listed

TG Therapeutics, Inc.

TGTXNasdaqCIK 1001316HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$240.3m, Q2 FY2026
Operating income$21.7m, Q2 FY2026
Net income$7.8m, Q2 FY2026
TG Therapeutics, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m166Revenue, Q3 FY2023, three months to 2023-09-30$165.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-07, accession 0001437749-24-033948.Report this figure44.0Revenue, Q4 FY2023, three months to 2023-12-31$44.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure63.5Revenue, Q1 FY2024, three months to 2024-03-31$63.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-09, accession 0001437749-25-015804.Report this figure73.5Revenue, Q2 FY2024, three months to 2024-06-30$73.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-08, accession 0001437749-25-025745.Report this figure83.9Revenue, Q3 FY2024, three months to 2024-09-30$83.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure108Revenue, Q4 FY2024, three months to 2024-12-31$108.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure121Revenue, Q1 FY2025, three months to 2025-03-31$120.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure141Revenue, Q2 FY2025, three months to 2025-06-30$141.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure162Revenue, Q3 FY2025, three months to 2025-09-30$161.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure193Revenue, Q4 FY2025, three months to 2025-12-31$192.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure205Revenue, Q1 FY2026, three months to 2026-03-31$204.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure240Revenue, Q2 FY2026, three months to 2026-06-30$240.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure
Cost of revenue$m3.5Cost of revenue, Q3 FY2023, three months to 2023-09-30$3.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-07, accession 0001437749-24-033948.Report this figure7.9Cost of revenue, Q4 FY2023, three months to 2023-12-31$7.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure5.4Cost of revenue, Q1 FY2024, three months to 2024-03-31$5.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-09, accession 0001437749-25-015804.Report this figure8.3Cost of revenue, Q2 FY2024, three months to 2024-06-30$8.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-08, accession 0001437749-25-025745.Report this figure9.3Cost of revenue, Q3 FY2024, three months to 2024-09-30$9.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure15.4Cost of revenue, Q4 FY2024, three months to 2024-12-31$15.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure15.5Cost of revenue, Q1 FY2025, three months to 2025-03-31$15.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure18.9Cost of revenue, Q2 FY2025, three months to 2025-06-30$18.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure28.1Cost of revenue, Q3 FY2025, three months to 2025-09-30$28.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure38.1Cost of revenue, Q4 FY2025, three months to 2025-12-31$38.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure33.5Cost of revenue, Q1 FY2026, three months to 2026-03-31$33.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure41.2Cost of revenue, Q2 FY2026, three months to 2026-06-30$41.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure
Research and development$m14.8Research and development, Q3 FY2023, three months to 2023-09-30$14.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0001437749-24-033948.Report this figure17.4Research and development, Q4 FY2023, three months to 2023-12-31$17.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure32.7Research and development, Q1 FY2024, three months to 2024-03-31$32.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-09, accession 0001437749-25-015804.Report this figure17.6Research and development, Q2 FY2024, three months to 2024-06-30$17.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-08, accession 0001437749-25-025745.Report this figure20.1Research and development, Q3 FY2024, three months to 2024-09-30$20.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure23.9Research and development, Q4 FY2024, three months to 2024-12-31$23.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure46.4Research and development, Q1 FY2025, three months to 2025-03-31$46.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure31.8Research and development, Q2 FY2025, three months to 2025-06-30$31.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure40.9Research and development, Q3 FY2025, three months to 2025-09-30$40.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure41.2Research and development, Q4 FY2025, three months to 2025-12-31$41.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure48.4Research and development, Q1 FY2026, three months to 2026-03-31$48.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure95.3Research and development, Q2 FY2026, three months to 2026-06-30$95.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure
Selling, general and administrative$m32.8Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$32.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-07, accession 0001437749-24-033948.Report this figure31.2Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$31.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure34.6Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$34.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-09, accession 0001437749-25-015804.Report this figure38.8Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$38.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-08, accession 0001437749-25-025745.Report this figure42.0Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$42.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure39.0Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$39.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure50.3Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$50.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure55.6Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$55.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure63.4Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$63.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure62.7Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$62.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure88.2Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$88.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure82.1Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$82.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure
Operating income$m115Operating income, Q3 FY2023, three months to 2023-09-30$114.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0001437749-24-033948.Report this figure(12.5)Operating income, Q4 FY2023, three months to 2023-12-31−$12.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure(9.3)Operating income, Q1 FY2024, three months to 2024-03-31−$9.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-09, accession 0001437749-25-015804.Report this figure8.8Operating income, Q2 FY2024, three months to 2024-06-30$8.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-08, accession 0001437749-25-025745.Report this figure12.4Operating income, Q3 FY2024, three months to 2024-09-30$12.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure29.9Operating income, Q4 FY2024, three months to 2024-12-31$29.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure8.6Operating income, Q1 FY2025, three months to 2025-03-31$8.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure34.8Operating income, Q2 FY2025, three months to 2025-06-30$34.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure29.4Operating income, Q3 FY2025, three months to 2025-09-30$29.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure50.5Operating income, Q4 FY2025, three months to 2025-12-31$50.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure34.8Operating income, Q1 FY2026, three months to 2026-03-31$34.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure21.7Operating income, Q2 FY2026, three months to 2026-06-30$21.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure
Interest expense$m3.7Interest expense, Q3 FY2023, three months to 2023-09-30$3.7m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-06, accession 0001437749-23-030412.Report this figure2.4Interest expense, Q4 FY2023, three months to 2023-12-31$2.4m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-29, accession 0001437749-24-006144. Derived: 12-month figure less the 9-month figure.Report this figure2.3Interest expense, Q1 FY2024, three months to 2024-03-31$2.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-06, accession 0001437749-24-014849.Report this figure4.0Interest expense, Q2 FY2024, three months to 2024-06-30$4.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-08, accession 0001437749-25-025745.Report this figure10.8Interest expense, Q3 FY2024, three months to 2024-09-30$10.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure7.1Interest expense, Q4 FY2024, three months to 2024-12-31$7.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure6.8Interest expense, Q1 FY2025, three months to 2025-03-31$6.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure6.7Interest expense, Q2 FY2025, three months to 2025-06-30$6.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure6.7Interest expense, Q3 FY2025, three months to 2025-09-30$6.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure6.5Interest expense, Q4 FY2025, three months to 2025-12-31$6.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure7.7Interest expense, Q1 FY2026, three months to 2026-03-31$7.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure16.6Interest expense, Q2 FY2026, three months to 2026-06-30$16.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0001437749-24-033948.Report this figure0.4Income tax, Q4 FY2023, three months to 2023-12-31$390.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$29.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-09, accession 0001437749-25-015804.Report this figure(0.3)Income tax, Q2 FY2024, three months to 2024-06-30−$328.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-08, accession 0001437749-25-025745.Report this figure0.4Income tax, Q3 FY2024, three months to 2024-09-30$388.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure2.1Income tax, Q4 FY2024, three months to 2024-12-31$2.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure0.4Income tax, Q1 FY2025, three months to 2025-03-31$408.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure2.7Income tax, Q2 FY2025, three months to 2025-06-30$2.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure(365)Income tax, Q3 FY2025, three months to 2025-09-30−$365.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure22.1Income tax, Q4 FY2025, three months to 2025-12-31$22.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure0.6Income tax, Q1 FY2026, three months to 2026-03-31$586.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure2.5Income tax, Q2 FY2026, three months to 2026-06-30$2.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure
Net income$m114Net income, Q3 FY2023, three months to 2023-09-30$113.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0001437749-24-033948.Report this figure(14.4)Net income, Q4 FY2023, three months to 2023-12-31−$14.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure(10.7)Net income, Q1 FY2024, three months to 2024-03-31−$10.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure6.9Net income, Q2 FY2024, three months to 2024-06-30$6.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure3.9Net income, Q3 FY2024, three months to 2024-09-30$3.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure23.3Net income, Q4 FY2024, three months to 2024-12-31$23.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure5.1Net income, Q1 FY2025, three months to 2025-03-31$5.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure28.2Net income, Q2 FY2025, three months to 2025-06-30$28.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure391Net income, Q3 FY2025, three months to 2025-09-30$390.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure23.0Net income, Q4 FY2025, three months to 2025-12-31$23.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure19.8Net income, Q1 FY2026, three months to 2026-03-31$19.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure7.8Net income, Q2 FY2026, three months to 2026-06-30$7.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure
Diluted EPS$ per share0.73Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.73 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0001437749-24-033948.Report this figurenot reported(0.07)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-09, accession 0001437749-25-015804.Report this figure0.04Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-08, accession 0001437749-25-025745.Report this figure0.02Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figurenot reported0.03Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure0.17Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure2.43Diluted EPS, Q3 FY2025, three months to 2025-09-30$2.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figurenot reported0.12Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure0.05Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure
Basic EPS$ per share0.80Basic EPS, Q3 FY2023, three months to 2023-09-30$0.80 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0001437749-24-033948.Report this figurenot reported(0.07)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-09, accession 0001437749-25-015804.Report this figure0.05Basic EPS, Q2 FY2024, three months to 2024-06-30$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-08, accession 0001437749-25-025745.Report this figure0.03Basic EPS, Q3 FY2024, three months to 2024-09-30$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figurenot reported0.03Basic EPS, Q1 FY2025, three months to 2025-03-31$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure0.19Basic EPS, Q2 FY2025, three months to 2025-06-30$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure2.69Basic EPS, Q3 FY2025, three months to 2025-09-30$2.69 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figurenot reported0.14Basic EPS, Q1 FY2026, three months to 2026-03-31$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure0.05Basic EPS, Q2 FY2026, three months to 2026-06-30$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure

Balance sheet

Cash and equivalents$482.6m, Q2 FY2026
Long-term debt$745.4m, Q2 FY2026
Shareholders' equity$604.1m, Q2 FY2026
TG Therapeutics, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m151Cash and equivalents, Q3 FY2023, at 2023-09-30$150.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001437749-24-033948.Report this figure92.9Cash and equivalents, FY2023, at 2023-12-31$92.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-27, accession 0001437749-26-006133.Report this figure75.5Cash and equivalents, Q1 FY2024, at 2024-03-31$75.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-09, accession 0001437749-25-015804.Report this figure82.9Cash and equivalents, Q2 FY2024, at 2024-06-30$82.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-08, accession 0001437749-25-025745.Report this figure196Cash and equivalents, Q3 FY2024, at 2024-09-30$195.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure180Cash and equivalents, FY2024, at 2024-12-31$179.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-27, accession 0001437749-26-006133.Report this figure132Cash and equivalents, Q1 FY2025, at 2025-03-31$132.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure129Cash and equivalents, Q2 FY2025, at 2025-06-30$129.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure74.1Cash and equivalents, Q3 FY2025, at 2025-09-30$74.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure79.1Cash and equivalents, FY2025, at 2025-12-31$79.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure442Cash and equivalents, Q1 FY2026, at 2026-03-31$442.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure483Cash and equivalents, Q2 FY2026, at 2026-06-30$482.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure
Current assets$m319Current assets, Q3 FY2023, at 2023-09-30$319.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-06, accession 0001437749-23-030412.Report this figure318Current assets, FY2023, at 2023-12-31$317.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-03, accession 0001437749-25-005908.Report this figure361Current assets, Q1 FY2024, at 2024-03-31$360.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-06, accession 0001437749-24-014849.Report this figure389Current assets, Q2 FY2024, at 2024-06-30$389.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-09, accession 0001437749-24-025853.Report this figure574Current assets, Q3 FY2024, at 2024-09-30$574.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001437749-24-033948.Report this figure566Current assets, FY2024, at 2024-12-31$566.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-27, accession 0001437749-26-006133.Report this figure645Current assets, Q1 FY2025, at 2025-03-31$644.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-09, accession 0001437749-25-015804.Report this figure664Current assets, Q2 FY2025, at 2025-06-30$664.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-08, accession 0001437749-25-025745.Report this figure600Current assets, Q3 FY2025, at 2025-09-30$599.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure631Current assets, FY2025, at 2025-12-31$630.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure1,087Current assets, Q1 FY2026, at 2026-03-31$1.09bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure1,146Current assets, Q2 FY2026, at 2026-06-30$1.15bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure
Total assets$m331Total assets, Q3 FY2023, at 2023-09-30$331.1m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-06, accession 0001437749-23-030412.Report this figure330Total assets, FY2023, at 2023-12-31$329.6m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-03, accession 0001437749-25-005908.Report this figure373Total assets, Q1 FY2024, at 2024-03-31$373.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-06, accession 0001437749-24-014849.Report this figure401Total assets, Q2 FY2024, at 2024-06-30$401.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-09, accession 0001437749-24-025853.Report this figure586Total assets, Q3 FY2024, at 2024-09-30$586.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001437749-24-033948.Report this figure578Total assets, FY2024, at 2024-12-31$577.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-27, accession 0001437749-26-006133.Report this figure657Total assets, Q1 FY2025, at 2025-03-31$656.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-09, accession 0001437749-25-015804.Report this figure703Total assets, Q2 FY2025, at 2025-06-30$702.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-08, accession 0001437749-25-025745.Report this figure1,025Total assets, Q3 FY2025, at 2025-09-30$1.03bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure1,063Total assets, FY2025, at 2025-12-31$1.06bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure1,529Total assets, Q1 FY2026, at 2026-03-31$1.53bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure1,640Total assets, Q2 FY2026, at 2026-06-30$1.64bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure
Current liabilities$m57.7Current liabilities, Q3 FY2023, at 2023-09-30$57.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-06, accession 0001437749-23-030412.Report this figure53.7Current liabilities, FY2023, at 2023-12-31$53.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-03, accession 0001437749-25-005908.Report this figure99.7Current liabilities, Q1 FY2024, at 2024-03-31$99.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-06, accession 0001437749-24-014849.Report this figure109Current liabilities, Q2 FY2024, at 2024-06-30$108.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-09, accession 0001437749-24-025853.Report this figure125Current liabilities, Q3 FY2024, at 2024-09-30$125.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001437749-24-033948.Report this figure90.7Current liabilities, FY2024, at 2024-12-31$90.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-27, accession 0001437749-26-006133.Report this figure160Current liabilities, Q1 FY2025, at 2025-03-31$160.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-09, accession 0001437749-25-015804.Report this figure172Current liabilities, Q2 FY2025, at 2025-06-30$171.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-08, accession 0001437749-25-025745.Report this figure157Current liabilities, Q3 FY2025, at 2025-09-30$156.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure154Current liabilities, FY2025, at 2025-12-31$153.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure187Current liabilities, Q1 FY2026, at 2026-03-31$187.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure268Current liabilities, Q2 FY2026, at 2026-06-30$268.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure
Total liabilities$m166Total liabilities, Q3 FY2023, at 2023-09-30$166.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-06, accession 0001437749-23-030412.Report this figure169Total liabilities, FY2023, at 2023-12-31$169.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-03, accession 0001437749-25-005908.Report this figure213Total liabilities, Q1 FY2024, at 2024-03-31$213.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-06, accession 0001437749-24-014849.Report this figure224Total liabilities, Q2 FY2024, at 2024-06-30$223.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-09, accession 0001437749-24-025853.Report this figure394Total liabilities, Q3 FY2024, at 2024-09-30$393.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001437749-24-033948.Report this figure355Total liabilities, FY2024, at 2024-12-31$355.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-27, accession 0001437749-26-006133.Report this figure419Total liabilities, Q1 FY2025, at 2025-03-31$419.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-09, accession 0001437749-25-015804.Report this figure426Total liabilities, Q2 FY2025, at 2025-06-30$426.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-08, accession 0001437749-25-025745.Report this figure418Total liabilities, Q3 FY2025, at 2025-09-30$417.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure415Total liabilities, FY2025, at 2025-12-31$415.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure946Total liabilities, Q1 FY2026, at 2026-03-31$945.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure1,036Total liabilities, Q2 FY2026, at 2026-06-30$1.04bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure
Long-term debt$m98.9Long-term debt, Q3 FY2023, at 2023-09-30$98.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-06, accession 0001437749-23-030412.Report this figure100Long-term debt, FY2023, at 2023-12-31$100.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-03, accession 0001437749-25-005908.Report this figure101Long-term debt, Q1 FY2024, at 2024-03-31$101.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-06, accession 0001437749-24-014849.Report this figure103Long-term debt, Q2 FY2024, at 2024-06-30$102.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-09, accession 0001437749-24-025853.Report this figure244Long-term debt, Q3 FY2024, at 2024-09-30$244.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-07, accession 0001437749-24-033948.Report this figure244Long-term debt, FY2024, at 2024-12-31$244.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-27, accession 0001437749-26-006133.Report this figure245Long-term debt, Q1 FY2025, at 2025-03-31$244.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-09, accession 0001437749-25-015804.Report this figure245Long-term debt, Q2 FY2025, at 2025-06-30$245.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-08, accession 0001437749-25-025745.Report this figure245Long-term debt, Q3 FY2025, at 2025-09-30$245.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure246Long-term debt, FY2025, at 2025-12-31$245.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure745Long-term debt, Q1 FY2026, at 2026-03-31$745.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure745Long-term debt, Q2 FY2026, at 2026-06-30$745.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure
Current portion of debt$m0.0Current portion of debt, Q3 FY2023, at 2023-09-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-11-06, accession 0001437749-23-030412.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m165Shareholders' equity, Q3 FY2023, at 2023-09-30$164.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0001437749-24-033948.Report this figure161Shareholders' equity, FY2023, at 2023-12-31$160.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-27, accession 0001437749-26-006133.Report this figure160Shareholders' equity, Q1 FY2024, at 2024-03-31$160.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure178Shareholders' equity, Q2 FY2024, at 2024-06-30$177.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure192Shareholders' equity, Q3 FY2024, at 2024-09-30$192.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure222Shareholders' equity, FY2024, at 2024-12-31$222.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure237Shareholders' equity, Q1 FY2025, at 2025-03-31$237.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure276Shareholders' equity, Q2 FY2025, at 2025-06-30$276.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure607Shareholders' equity, Q3 FY2025, at 2025-09-30$607.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure648Shareholders' equity, FY2025, at 2025-12-31$648.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure583Shareholders' equity, Q1 FY2026, at 2026-03-31$583.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure604Shareholders' equity, Q2 FY2026, at 2026-06-30$604.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure

Cash flow

Operating cash flow$39.3m, Q2 FY2026
Capital expenditure$293.0k, Q2 FY2026
TG Therapeutics, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m83.7Operating cash flow, Q3 FY2023, three months to 2023-09-30$83.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001437749-24-033948. Derived: 9-month figure less the 6-month figure.Report this figure(13.2)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$13.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure(8.2)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$8.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-09, accession 0001437749-25-015804.Report this figure5.5Operating cash flow, Q2 FY2024, three months to 2024-06-30$5.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-08, accession 0001437749-25-025745. Derived: 6-month figure less the 3-month figure.Report this figure(12.2)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$12.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001437749-25-033363. Derived: 9-month figure less the 6-month figure.Report this figure(25.6)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$25.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure(28.7)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$28.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure7.4Operating cash flow, Q2 FY2025, three months to 2025-06-30$7.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001437749-26-025955. Derived: 6-month figure less the 3-month figure.Report this figure(23.2)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$23.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001437749-25-033363. Derived: 9-month figure less the 6-month figure.Report this figure19.7Operating cash flow, Q4 FY2025, three months to 2025-12-31$19.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure(17.9)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$17.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure39.3Operating cash flow, Q2 FY2026, three months to 2026-06-30$39.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001437749-26-025955. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$mnot reported0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-09, accession 0001437749-25-015804.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-08, accession 0001437749-25-025745. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$24.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001437749-25-033363. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$21.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$25.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$42.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001437749-26-025955. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$80.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001437749-25-033363. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$67.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001437749-26-006133. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$51.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure0.3Capital expenditure, Q2 FY2026, three months to 2026-06-30$293.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001437749-26-025955. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)157.28m, Q2 FY2026
TG Therapeutics, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares135Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30135,327,035 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-06, accession 0001437749-23-030412.Report this figure140Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31140,312,269 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-05-08, accession 0001558370-23-008385.Report this figure142Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30141,503,738 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-09, accession 0001437749-24-025853.Report this figure156Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30155,871,749 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0001437749-24-033948.Report this figure146Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31146,209,213 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-09, accession 0001437749-25-015804.Report this figure159Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30159,423,571 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-08, accession 0001437749-25-025745.Report this figure161Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30160,714,388 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure163Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31162,769,202 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure163Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30162,559,404 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure161Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30160,997,977 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001437749-25-033363.Report this figure160Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31160,062,326 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001437749-26-015246.Report this figure157Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30157,281,850 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure

Shares outstanding: 153.07mShares outstanding, period not labelled, at 2026-08-03153,069,053 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001437749-26-025955.Report this figure at Aug 3, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. Listed shows no prices and gives no investment advice.